Sort by
Refine Your Search
-
funded for four years by the recently awarded ERC Starting grant ‘ReCNNSTRCT’. Biocatalysis uses enzymes to replace traditional catalysts. This technology has already established sustainable enzymatic
-
PhD Investigating Modern Organizational Structures & Decision-Making through experimental approaches
description How are strategic decisions shaped by organizational structures? What are the effects of modern organizational structures like flat hierarchies that provide autonomy or technology-enabled self
-
heterostructure engineering exploiting their angle-dependent moiré patterns. Experience with van der Waals heterostructures/2D materials, optics and/or electronics are a plus, but not a must. You will use advanced
-
ferroelectric or using (circularly polarized) light, and through van der Waals heterostructure engineering exploiting their angle-dependent moiré patterns. Experience with van der Waals heterostructures/2D
-
international business, operations management, industrial engineering, or other related fields in business and economics. Conditions of employment We offer you in accordance with the Collective Labour Agreement
-
Biological sciences » Biological engineering Researcher Profile First Stage Researcher (R1) Country Netherlands Application Deadline 15 Apr 2024 - 11:59 (Europe/Amsterdam) Type of Contract Temporary Job Status
-
part of the agreement and the successful candidates will be enrolled in the Graduate School of Science and Engineering. This training program will be completed with training on artificial intelligence
-
the agreement and the successful candidates will be enrolled in the Graduate School of Science and Engineering. This training program will be completed with training on artificial intelligence and automatization
-
training program is part of the agreement and the successful candidates will be enrolled in the Graduate School of Science and Engineering. This training program will be completed with training on artificial
-
The vacancy is within the groups of Prof. Dr. Klaas Poelstra and Prof. Dr. Peter Olinga at the Groningen Research Institute of Pharmacy, Faculty of Science and Engineering, University of Groningen and Prof. dr